Sign up to save your podcasts
Or
Share An FDA Self-Audit of Continuous Manufacturing for Drug Products
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
An FDA Self-Audit of Continuous Manufacturing for Drug Products
Continuous manufacturing (CM) technology has the potential to improve product quality and reliability, lower manufacturing costs, reduce waste, decrease inventory, and increase manufacturing flexibility and agility in response to product demand.
View all episodes
By U.S. Food and Drug Administration, Center for Drug Evaluation and ResearchContinuous manufacturing (CM) technology has the potential to improve product quality and reliability, lower manufacturing costs, reduce waste, decrease inventory, and increase manufacturing flexibility and agility in response to product demand.